Education
About Us
Working with TipRanks
Follow Us
Vivani Medical (VANI)
NASDAQ:VANI
VANI Stock Chart & Stats
$1.35
-$0.02(-1.59%)
At close: 4:00 PM EST
$1.35
-$0.02(-1.59%)
Day’s Range― - ―
52-Week Range$0.91 - $1.92
Previous CloseN/A
Volume36.09K
Average Volume (3M)216.92K
Market Cap
$104.22M
Enterprise Value$88.25M
Total Cash (Recent Filing)$2.63M
Total Debt (Recent Filing)$18.29M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Mar 26, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding69,248,535
10 Day Avg. Volume237,036
30 Day Avg. Volume216,922
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.62
Price to Sales (P/S)0.00
P/FCF Ratio-2.99
Enterprise Value/Market Cap0.85
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-454.88
Enterprise Value/Ebitda-3.36
Forecast
1Y Price Target
$4.00Price Target Upside196.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentVivani Medical is preparing to start its clinical development for NPM-139 for chronic weight management, with the potential to demonstrate efficacy comparable to Wegovy.
Efficacy And SafetyNPM-139 has shown approximately 20% weight loss maintained for over six months in an animal study, suggesting a promising efficacy for weight management.
Financial PositionThe company's cash position was significantly strengthened by a direct offering and private placement, raising $15.7M.
Bears Say
Capital RequirementsThe company may need to raise additional capital within the next 12 months.
Clinical And Regulatory RisksRisks include failure of NPM-139 in clinical trials, failure to secure regulatory approval, failure to achieve commercial success, and dilution risk.
Financial PerformanceVivani reported a net loss of ($6.5M) with $4.0M in cash and no debt, raising $15.7M through recent financing.
Vivani Medical News
VANI FAQ
What was Vivani Medical’s price range in the past 12 months?
Vivani Medical lowest stock price was $0.91 and its highest was $1.92 in the past 12 months.
What is Vivani Medical’s market cap?
Vivani Medical’s market cap is $104.22M.
When is Vivani Medical’s upcoming earnings report date?
Vivani Medical’s upcoming earnings report date is Mar 26, 2026 which is in 124 days.
How were Vivani Medical’s earnings last quarter?
Vivani Medical released its earnings results on Nov 13, 2025. The company reported -$0.11 earnings per share for the quarter, the consensus estimate of -$0.11 by $0.
Is Vivani Medical overvalued?
According to Wall Street analysts Vivani Medical’s price is currently Undervalued.
Does Vivani Medical pay dividends?
Vivani Medical does not currently pay dividends.
What is Vivani Medical’s EPS estimate?
Vivani Medical’s EPS estimate is -0.09.
How many shares outstanding does Vivani Medical have?
Vivani Medical has 69,248,535 shares outstanding.
What happened to Vivani Medical’s price movement after its last earnings report?
Vivani Medical reported an EPS of -$0.11 in its last earnings report, expectations of -$0.11. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of Vivani Medical?
Currently, no hedge funds are holding shares in VANI
Vivani Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (196.30% Upside)
$4.00 (196.30% Upside)
Insider Transactions
Bought Shares
Worth $12.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.2%
Last 30 Days ▲ 13.6%
Last 30 Days ▲ 13.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.12%
12-Months-Change
Fundamentals
Return on Equity
-265.02%
Trailing 12-Months
Asset Growth
-40.06%
Trailing 12-Months
Company Description
Vivani Medical
Vivani Medical (VANI) is a medical technology company specializing in the development of innovative implantable solutions for chronic disease management. The company operates in the healthcare sector, focusing on creating products that enhance patient outcomes and quality of life. Vivani Medical's core products include advanced drug delivery systems and neurostimulation devices that are designed to address various medical conditions.
VANI Stock 12 Month Forecast
Average Price Target
$4.00
▲(196.30% Upside)
Technical Analysis
Ownership Overview
41.41% Insiders
2.39% Mutual Funds
1.84% Other Institutional Investors
52.72% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---